Federal clinical recommendations for primary immunodeficiencies in adults: prerequisites, problems, solutions


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Clinical recommendations (CR) - is a consensus for the diagnosis and treatment of patients with certain nosology, created by experts in various fields of medicine based on the experience of experts, and data from multicenter trails. CR optimize patient management, minimizing the risk of medical error. CR of a particular importance are CR for the rare diseases, because the majority of doctors lack of experience. One of the illustrations of such rare diseases are primary immunodeficiencies (PID). Owing to the development of fundamental immunology, diagnostic and therapeutic options, these patients may survive to adulthood, so this problem has gone beyond the field of pediatricians. Now the probability to meet such patients is much higher for many doctors of different specialities. The paper discusses the problem of PID in Russia, the challenges of creating a CR on this disease and the ways of their solution.

作者简介

E Latysheva

Institute of Immunology

Email: ealat@mail.ru
Moscow, Russia

N Ilina

Institute of Immunology

Moscow, Russia

参考

  1. Di Renzo M., Pasqui A.L., Auteri A. Common variable immunodeficiency: a review. Clin. Exp. Med. 2004, v. 3, р. 211-217.
  2. Arrendondo-Vega F.X., Santisteban I., Notarangelo L.D. et al. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Hum. Mutat. 1998, v. 11, р. 482.
  3. Zama D., Cocchi I., Masetti R. et al. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea. Ital. J. Pediatr. 2014, v. 40, р. 68.
  4. Bussone G., Mouthon L. Late onset of primary immune deficiencies. Presse Med. 2010, v. 39, р. 196-207.
  5. Notarangelo L.D., Fischer A., Geha R.S. et al. Primary immunodeficiencies: 2009 update. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies. J. Allergy Clin. Immunol. 2009, v. 124, р. 1161-1178.
  6. Bates C.A., Ellison M.C., Lynch D.A. et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J. Allergy Clin. Immunol. 2004, v. 114, р. 415-421.
  7. Quinti I., Soresina A., Spadaro G. et al. Italian Primary Immunodeficiency Network Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J. Clin. Immunol. 2007, v. 27, р. 308-316.
  8. Verma N., Thaventhiran A., Gathmann B. et al. Therapeutic Management of Primary Immunodeficiency in Older Patients. Drugs Aging. 2013, v. 30, р. 503-512.
  9. Gathmann B., Binder N., Ehl S., Kindle G. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin. Exp. Immunol. 2012, v. 167, р. 479-491.

版权所有 © Pharmarus Print Media, 2015

##common.cookie##